Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Language Outcomes in Deaf Children

16 novembre 2026 aggiornato da: The University of Tennessee, Knoxville

Dati pre e post descrittivi dei risultati linguistici nei bambini sordi

The goal of this single-arm, non-randomized clinical trial is to learn how deaf children's signed language discourse changes over the course of a school year while receiving their usual educational instruction. The study focuses on deaf children in PreKindergarten through Grade 3 who use signed language. The main questions it aims to answer are: Do deaf children show growth in signed expression from the beginning to the end of the school year? How does growth in signed expression vary? Participants will take part in their regular classroom instruction as provided by their school. They will create signed language videos in response to three prompts (narrative, informational, and opinion) at the beginning and end of the school year. They will have their signing samples scored using a standardized rubric for signed language discourse.

Panoramica dello studio

Stato

Terminato

Descrizione dettagliata

This study was conducted as a multisite, single-arm, non-randomized pretest-posttest cohort trial examining change in discourse-level signed expression among deaf children across one academic year. All participants received their usual educational instruction as delivered in their classrooms. This naturally occurring educational instruction constituted the study intervention. No alternative instructional conditions or comparison groups were included. The study was designed to evaluate change over time within a single study arm receiving standard educational practice. Data were collected at two time points with a pretest at the beginning of the academic year and a posttest at the end of the academic year. At each time point, children completed three expressive language tasks representing narrative, informational, and opinion discourse types. Teachers followed a standardized administration protocol to ensure comprehension of prompts, provide planning time, and support independent production of signed responses. Signed language samples were recorded using classroom-based video equipment routinely used for instruction. Identical procedures were used at pretest and posttest to support consistency of measurement across time. Signing samples were scored using the Signed Language Composition Assessment (SLCA), a discourse-based rubric developed for signed language. Each sample received trait-level scores for Orientation to Purpose, Idea Development, and Length and Organization, rated on a six-point scale with genre-specific behavioral anchors adapted from established discourse and writing frameworks. Two raters independently scored 20% of the samples to ensure interrater reliability. Scores were considered in agreement if identical or differing by no more than 0.5 points. Discrepancies were resolved through a structured consensus process involving joint review of relevant video segments and discussion of scoring anchors. Trait-level and total scores at pretest and posttest formed the basis for all analyses. Child demographic and language background data were collected through a teacher-completed online survey during the academic year. Variables included age, grade, race/ethnicity, and gender/sex. The analytic approach focused on within-arm change over time to describe patterns of signed language growth under usual educational practice. Growth in signed expression from pretest to posttest was examined across grades and discourses. The study was designed to document change over time in signed language outcomes during routine educational instruction and establishes developmental benchmarks for discourse-level signed expression to inform future controlled and randomized trials.

Tipo di studio

Osservativo

Iscrizione (Effettivo)

181

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Luoghi di studio

    • Tennessee
      • Knoxville, Tennessee, Stati Uniti, 37996
        • University of Tennessee, Knoxville

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

Da 4 anni a 10 anni (Bambino)

Accetta volontari sani

No

Sessi ammissibili allo studio

Tutto

Metodo di campionamento

Campione non probabilistico

Popolazione di studio

Deaf children between 4 and 10 years old attending deaf education programs

Descrizione

Inclusion Criteria:

  • Deaf children between 4 and 10 years old attending deaf education programs

Exclusion Criteria:

  • Non-deaf children

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Modelli osservazionali: COHORT
  • Prospettive temporali: PROSPECTIVE

Coorti e interventi

Gruppo / Coorte
Intervento / Trattamento
Deaf children

Deaf children attending deaf education programs

Deaf children are receiving business-as-usual instruction in sign language in deaf education programs.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Sign Language Skills
Lasso di tempo: From enrollment to the end of treatment 9 academic months later.

Deaf children's sign language skills will be evaluated using discourse-based measures. Responses to language prompts will be scored with the Sign Language Complexity Assessment (SLCA). The SLCA rates three discourse traits-orientation to purpose, idea development, and organization - on a scale from 0 (no expression) to 6 (multi-paragraph expression). Higher scores indicate more advanced sign language development.

From enrollment to the end of treatment 9 academic months later.

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Written Language Skills
Lasso di tempo: From enrollment to the end of treatment 9 academic months later.

Deaf children's written language skills will be evaluated using discourse-based measures. Responses to language prompts will be scored with the parallel writing measure for Sign Language Complexity Assessment (SLCA). The SLCA rates three discourse traits -orientation to purpose, idea development, and organization - on a scale from 0 (no expression) to 6 (multi-paragraph expression). Higher scores indicate more advanced written language development.

From enrollment to the end of treatment 9 academic months later.

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Pubblicazioni e link utili

La persona responsabile dell'inserimento delle informazioni sullo studio fornisce volontariamente queste pubblicazioni. Questi possono riguardare qualsiasi cosa relativa allo studio.

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

1 agosto 2024

Completamento primario (Effettivo)

30 settembre 2025

Completamento dello studio (Effettivo)

30 settembre 2025

Date di iscrizione allo studio

Primo inviato

4 dicembre 2024

Primo inviato che soddisfa i criteri di controllo qualità

4 dicembre 2024

Primo Inserito (Effettivo)

9 dicembre 2024

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

17 novembre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

16 novembre 2026

Ultimo verificato

1 novembre 2026

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • 478856
  • R21DC021024 (Sovvenzione/contratto NIH degli Stati Uniti)

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

SÌ

Descrizione del piano IPD

Under a data-sharing agreement that is in compliance with the internal policy at UTK, non-identifying data can be shared with other researchers for a minimum of 10 years on the University of Tennessee Research and Creative Exchange (TRACE). The raw data consists of videos of teachers, which will not be shared to maintain confidentiality. The processed data will be in the form of percentages for individual teachers across an academic year documented in a .csv file (Excel). Center for Open Science Foundation (OSF) is a free and open source project management tool that supports researchers throughout their entire project lifecycle. OSF also allows people to locate this data through project names, author names, and study keywords.

Periodo di condivisione IPD

December, 2026 to December, 2036

Criteri di accesso alla condivisione IPD

Researchers may contact the principal investigator for additional supporting information not available on OSF.

Tipo di informazioni di supporto alla condivisione IPD

  • STUDIO_PROTOCOLLO
  • CODICE_ANALITICO
  • RSI

Dati/documenti di studio

  1. Open Science Framework
    Commenti informativi:

    The study's de-identified individual participant data (IPD) include student-level pre- and post-assessment outcomes, demographic variables, and relevant instructional context measures. Supporting materials include data dictionaries, scoring protocols, and documentation of analytic procedures. These materials are available through an OSF project link.

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi